Batte, Anthony
Nakulima, Violah
Namazzi, Ruth
Aujo, Judith Caroline
Starr, Michelle C.
Schwaderer, Andrew L.
Lintner-Rivera, Michael
Ahumwire, Avias
Ogwal, Daniel
Tenywa, Emmanuel
Oyang, William
Ssenkusu, John M.
Bangirana, Paul
Idro, Richard
Kalyesubula, Robert
Dreyer, Gavin
McCulloch, Mignon
Bassat, Quique
John, Chandy C.
Goldstein, Stuart L.
Conroy, Andrea L.
Funding for this research was provided by:
Fogarty International Center (K43TW012586)
Division of Critical Care, Riley Hospital for Children
National Institute of Allergy and Infectious Diseases (R01 AI165946)
Article History
Received: 15 May 2025
Accepted: 9 July 2025
First Online: 15 July 2025
Declarations
:
: The study is approved by the Makerere University School of Biomedical Sciences Research Ethics Committee (SBS-REC, protocol number: SBS-2022-173), Indiana University School of Medicine Institutional Review Board (IUSM- IRB, protocol number: 15144) and the Uganda National Council for Science and Technology (UNCST, protocol number: HS2794ES). The study will be conducted in accordance with legal and regulatory requirements, as well as the general principles outlined in the International Ethical Guidelines for Biomedical Research Involving Human Participants and the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.